Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuka Inoue

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Cancer Medicine|February 19, 2025
Prognostic Impact of Stimulator of Interferon Genes Expression in Triple Negative Breast CancerTetsuyo Maeda, Makiko Ono, Tomo Osako, et al.
Oncology Reports|November 24, 2016
MicroRNA-6826 and -6875 in plasma are valuable non‑invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancerTaiki Kijima, Shoichi Hazama, Ryouichi Tsunedomi, et al.
Breast Cancer (Tokyo, Japan)|April 26, 2017
A phase II, multicenter, single-arm study of tri-weekly low-dose nanoparticle albumin-bound paclitaxel chemotherapy for patients with metastatic or recurrent breast cancerShigeru Yamamoto, Noriko Maeda, Yukiko Nagashima, et al.
Cancer Science|September 25, 2016
Prediction of the efficacy of immunotherapy by measuring the integrity of cell-free DNA in plasma in colorectal cancerMasahiro Kitahara, Shoichi Hazama, Ryouichi Tsunedomi, et al.
Brain & Development|April 10, 2012
A severe form of epidermal nevus syndrome associated with brainstem and cerebellar malformations and neonatal medulloblastomaAkihisa Okumura, Tsubasa Lee, Mitsuru Ikeno, et al.
Oncology Letters|August 10, 2017
miR-196b, miR-378a and miR-486 are predictive biomarkers for the efficacy of vaccine treatment in colorectal cancerYoshitaro Shindo, Shoichi Hazama, Yusuke Nakamura, et al.
Molecular Cancer Research : MCR|November 29, 2022
MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast CancerNami Yamashita, Yoshihiro Morimoto, Atsushi Fushimi, et al.
Breast Cancer Research : BCR|June 16, 2025
Axillary adipose tissue-derived lymphatic endothelial cells exhibit distinct transcriptomic signatures reflecting lymphatic invasion status in breast cancerAsumi Iesato, Jun Suzuka, Kazutaka Otsuji, et al.
Cancer Science|September 17, 2013
UGT1A1*6, 1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI-treated metastatic colorectal cancer in two prospective studies in JapanShoichi Hazama, Hideyuki Mishima, Ryouichi Tsunedomi, et al.
Anticancer Research|July 31, 2014
Predictive biomarkers for the outcome of vaccination of five therapeutic epitope peptides for colorectal cancerShoichi Hazama, Hiroko Takenouchi, Ryouichi Tsunedomi, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Cancer Medicine|February 19, 2025
Prognostic Impact of Stimulator of Interferon Genes Expression in Triple Negative Breast CancerTetsuyo Maeda, Makiko Ono, Tomo Osako, et al.
Oncology Reports|November 24, 2016
MicroRNA-6826 and -6875 in plasma are valuable non‑invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancerTaiki Kijima, Shoichi Hazama, Ryouichi Tsunedomi, et al.
Breast Cancer (Tokyo, Japan)|April 26, 2017
A phase II, multicenter, single-arm study of tri-weekly low-dose nanoparticle albumin-bound paclitaxel chemotherapy for patients with metastatic or recurrent breast cancerShigeru Yamamoto, Noriko Maeda, Yukiko Nagashima, et al.
Cancer Science|September 25, 2016
Prediction of the efficacy of immunotherapy by measuring the integrity of cell-free DNA in plasma in colorectal cancerMasahiro Kitahara, Shoichi Hazama, Ryouichi Tsunedomi, et al.
Brain & Development|April 10, 2012
A severe form of epidermal nevus syndrome associated with brainstem and cerebellar malformations and neonatal medulloblastomaAkihisa Okumura, Tsubasa Lee, Mitsuru Ikeno, et al.
Oncology Letters|August 10, 2017
miR-196b, miR-378a and miR-486 are predictive biomarkers for the efficacy of vaccine treatment in colorectal cancerYoshitaro Shindo, Shoichi Hazama, Yusuke Nakamura, et al.
Molecular Cancer Research : MCR|November 29, 2022
MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast CancerNami Yamashita, Yoshihiro Morimoto, Atsushi Fushimi, et al.
Breast Cancer Research : BCR|June 16, 2025
Axillary adipose tissue-derived lymphatic endothelial cells exhibit distinct transcriptomic signatures reflecting lymphatic invasion status in breast cancerAsumi Iesato, Jun Suzuka, Kazutaka Otsuji, et al.
Cancer Science|September 17, 2013
UGT1A1*6, 1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI-treated metastatic colorectal cancer in two prospective studies in JapanShoichi Hazama, Hideyuki Mishima, Ryouichi Tsunedomi, et al.
Anticancer Research|July 31, 2014
Predictive biomarkers for the outcome of vaccination of five therapeutic epitope peptides for colorectal cancerShoichi Hazama, Hiroko Takenouchi, Ryouichi Tsunedomi, et al.
Pageof 8